Effect of l-carnitine on sleep quality in hemodialysis patients.

Effect of l-carnitine supplement and placebo on sleep quality in hemodialysis patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014030516848N1

Enrollment

Registered

2014-05-03

Start date

2014-03-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis. Extracorporeal dialysis

Interventions

Intervention 1: The intervention group will receive 500mg l-carnitine orally twice a day for 12 weeks. Intervention 2: The control group will receive tablet similar to l-carnitine as placebo orally tw

Treatment - Drugs

Placebo

The intervention group will receive 500mg l-carnitine orally twice a day for 12 weeks.

The control group will receive tablet similar to l-carnitine as placebo orally twice a day for 12 weeks.

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Signing informed consent, Being on hemodialysis three times a week for at least 6 months prior to the study, age over 18. Exclusion criteria: Refusal at any time to continue the study, History of l-carnitine , vit c and vit E consumption, History of transquilizers, hypnotics or sedatives consumption, History of severe neuropsychology, cardiac, respiratory, liver disease, History of renal transplantation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sleep quality. Timepoint: before intervention and three months later. Method of measurement: PSQI=Pittsburgh sleep quality index.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Hatami

Sabzevar University of Medical Science

hattamim@gmail.com+98 57 1444 6070

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026